ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 692738 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 692738; 2) Community: the network communities that were significantly associated with the response to NSC 692738; 3) Molecule: the relationships between components within communities and NSC 692738; 4) MDR: the compounds that were significantly associated with the NSC 692738.

NSC Compound Enrichment Correlation
NSC 741412 4-(5'-bromofuran-2'-yl)-3-bromo-but-3-en-2-one 0.0467178916101838 0.22309007
NSC 743220 N2-(4-fluorophenyl)-N3-(2-methoxyphenyl)-5-oxo-7-propyl-5H-[ 1,3]thiazolo[3,2-a]pyrimidine-2,3-dicarboxamide 0.0467178916101838 0.13900265
NSC 743862 Null 0.0467178916101838 0.34267609
NSC 747174 Null 0.0467178916101838 0.25743075
NSC 758664 Sirolimus [USAN] 0.0467178916101838 -0.187473
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.0467178916101842 0.44133827
NSC 176503 Fastigilin B 0.0467178916101842 0.36904524
NSC 180973 Tamoxifen citrate 0.0467178916101842 0.24472718
NSC 205555 Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- 0.0467178916101842 0.2018544
NSC 251190 [1-(2-PYRIDINYL)ETHYLIDENE]HYDRAZINECARBODITHIOIC ACID, METHYL ESTER 0.0467178916101842 0.19629725
Total:75  Current:64    [First] [Prev] [Next] [Last]